undamentalytics Newsletter
Sign in

Cytomed Therapeutics Ltd revenue

Cytomed Therapeutics Ltd's revenue was $248,384 in fiscal 2025, up 377.5% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025
Revenue52248
Growth on the year before—+377.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cytomed Therapeutics Ltd $248,384 377.5% —
Clene Inc. $197,000 -31.1% -36.9%
Cervomed Inc. $331,295 -95.7% -52.7%
Celldex Therapeutics, Inc. $158,000 -97.3% -63.5%
Cardiff Oncology, Inc. $508,000 -7.0% 7.2%
Ibio, Inc. $100,000 -75.0% -62.4%

Compare with peers

Head to head: CLNN vs GDTCCRVO vs GDTCCLDX vs GDTC

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cytomed Therapeutics Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cytomed Therapeutics Ltd.